MarketPeel
Insider Trading Intelligence
JZ

Jacqueline Zummo

TARA
CHF SCIENTIFIC OPERATIONS OFF · PROTARA THERAPEUTICS, INC. · CIK 0001798929
FILING MIX · LIFETIME52%/48%
BUYS
15
SELLS
14
TOTAL VALUE
$498.7K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
94,827
AVG SELL PX
$5.49
TRADE KIND
SHOWING 29 / 29
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Jacqueline Zummo, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%-0.64%+2.00%-2.64%-3.73%
14d3+33.33%-1.56%+2.84%-4.40%-3.45%
30d3+33.33%+0.63%+5.31%-4.69%-4.43%
60d3+100.00%-19.65%+5.47%-31.07%-31.07%
90d3(1 pending)+100.00%-25.35%+9.90%-35.26%-35.26%
180d3(2 pending)+100.00%-18.98%+17.28%-36.26%-36.26%
1y3(2 pending)+0.00%+14.57%+13.45%+1.11%+1.11%
2y3(3 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TARA · 94,827 shares · as of Apr 8, 2026
045,00090,000135,000180,000202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 14 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chief R&D Officer
1,134$5.40$6.1K94,827Apr 8, 2026Apr 9, 2026View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chief R&D Officer
22,598$5.26$118.9K95,961Apr 1, 2026Apr 2, 2026View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
3,724$6.67$24.8K118,559Jan 26, 2026Jan 27, 2026View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
6,578$5.60$36.8K122,283Jan 20, 2026Jan 22, 2026View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,000128,861Jan 16, 2026Jan 21, 2026View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
180,000180,000Jan 16, 2026Jan 21, 2026View →
TARA
PROTARA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
21,224$4.53$96.1K98,861Mar 26, 2025Mar 28, 2025View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
146,000146,000Jan 24, 2025Jan 28, 2025View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,500126,639Jan 24, 2025Jan 28, 2025View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
6,554$4.76$31.2K95,585Jan 21, 2025Jan 23, 2025View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
2,157$6.14$13.2K102,139Jan 3, 2025Jan 7, 2025View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
3,049$1.91$5.8K104,296Jan 19, 2024Jan 23, 2024View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
137,000137,000Jan 19, 2024Jan 23, 2024View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
23,000107,345Jan 19, 2024Jan 23, 2024View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
5,229$2.39$12.5K84,345Jan 10, 2024Jan 12, 2024View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
1,899$2.17$4.1K89,574Jan 3, 2024Jan 5, 2024View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,90091,473Jan 19, 2023Jan 20, 2023View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
119,300119,300Jan 19, 2023Jan 20, 2023View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
5,225$3.00$15.7K71,573Jan 10, 2023Jan 11, 2023View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
2,159$2.80$6.0K76,798Jan 3, 2023Jan 4, 2023View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
4,603$6.27$28.9K78,957Jan 10, 2022Jan 12, 2022View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
84,80084,800Jan 3, 2022Jan 5, 2022View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,10083,560Jan 3, 2022Jan 5, 2022View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
75,00075,000Jan 19, 2021Jan 21, 2021View →
TARA
PROTARA THERAPEUTICS, INC.
SALE
Chf Scientific Operations Off
4,653$21.16$98.5K69,460Jan 11, 2021Jan 13, 2021View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
45,50074,113Jan 10, 2020Jan 13, 2020View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
28,61328,613Jan 9, 2020Jan 13, 2020View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,07519,075Jan 9, 2020Jan 13, 2020View →
TARA
PROTARA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,5379,537Jan 9, 2020Jan 13, 2020View →
Other insiders · TARA
Loading peer insiders…
About this filer
CIK 0001798929
ROLE
Chf Scientific Operations Off
PRIMARY
TARA
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001798929DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback